Abstract
Vigabatrin is an antiepileptic that functions by increasing ɣ-aminobutyric acid (GABA) levels in the brain. Like other antiepileptics, it also causes neuropsychiatric side effects. Among these side effects, psychosis draws particular attention. Drug-induced psychosis has been reported in previous publications at the beginning of the drug, while psychosis reports during the cessation period are limited. We discussed the possible mechanisms of psychosis that can be seen in the use of vigabatrin in the light of the assumptions that GABA, glutamate and dopamine are involved in the formation of positive symptoms in psychosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
